aid: brii-biosciences

name: Brii BioSciences

description: 'Brii BioSciences Limited (stock code: 2137.HK) is a biotechnology company founded in 2018, developing therapies for high unmet medical needs, notably hepatitis B virus infection. Operating in China and the United States, the firm focuses on innovative therapeutic candidates and has a pipeline of unique programs. It employs a visionary leadership team and aims to improve patient health through advanced biotech research.'

url: https://www.briibio.com/api-evangelist/brii-biosciences/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-06 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-06'

modified: '2026-10-06'

tags:
- Biotech
- Monoclonal Antibodies
- Infectious Diseases
- Hepatitis B
- COVID-19
- Neuroscience
- China

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/brii-biosciences-hosts.yml
- type: TermsOfService
  url: https://www.briibio.com/en/terms-of-use/
- type: PrivacyPolicy
  url: https://www.briibio.com/en/privacy-statement/
- type: Leadership
  url: https://www.briibio.com/en/company/leadership/
- type: DomainSecurity
  url: security/brii-biosciences-domain-security.yml
- type: Website
  url: https://www.briibio.com

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  method: derived
  generated: '2026-10-06'
  generator: derive-coverage.py (pre-flight evidence)
  detail: >-
    the company publishes no developer documentation host and no machine-readable contract on its own domain
  evidence:
  - url: https://www.briibio.com
    status: 200
  - url: https://forgeglobal.com/brii-biosciences_stock/
    status: 403
x-enrichment:
  date: '2026-10-06'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local